FDA Adverse Event Malfunction Summary report: N

IVENIX, INC.

MDR report key: 23036961 · Received September 12, 2025

Report

Report Number
3014732157-2025-00986
Event Type
Malfunction
Date Received
September 12, 2025
Date of Event
May 20, 2025
Report Date
September 12, 2025
Manufacturer
FRESENIUS KABI USA, LLC
Product Code
FPA
UDI-DI
00811505030054
PMA / PMN Number
K183311
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Description of Event or Problem · 0

THE FOLLOWING HAS BEEN REPORTED: OCCLUSION DOWNSTREAM ALARM WHILE INFUSING VIA SECONDARY. 10ML SYRINGE FROM BD ATTACHED VIA SECONDARY VALVE, BUT NOT INFUSING. RN ABLE TO BACKPRIME WITH 10ML SYRINGE WITH NO ISSUE OR ALARM OCCURRING. RN CHANGED ADMINISTRATION SET AND NO UPSTREAM OCCLUSIONS OCCURRING ONCE SECONDARY BAG ATTACHED AND INFUSING. SYRINGE NOT ON RECOMMENDED MANUFACTURER LIST. DRUG USED: PRE-MED(ZOFRAN, DECADRON, BENADRYL) RN DRAWS PREMEDS UP INTO A 10ML SYRINGE. A PRELIMINARY REVIEW OF THE LOGS COULD NOT BE PERFORMED. THE SET WAS RETURNED FOR EVALUATION. NO DEFECTS WERE OBSERVED DURING VISUAL INSPECTION. THE GOLD FOIL CORRESPONDED TO THE SPECIFIC CODE SET-0013-25. THE SAMPLE WAS RETURNED WITHOUT SALINE SPIKE/DRIP CHAMBER. PRIMARY LINE INFUSION PASSED SUCCESSFULLY AND WAS TESTED WITH A SET RATE OF 0.5ML/HR AND SET VOLUME OF 0.1ML AND PRIMARY LINE WAS CONNECTED TO A SALINE SOLUTION BAG. THE PRIMARY BOLUS PRIME PROCESS PASSED SUCCESSFULLY. SECONDARY LINE INFUSION WAS TESTED WITH A SET RATE OF 1000ML/HR AND SET VOLUME OF 10 ML AND PRIMARY LINE WAS CONNECTED TO A SALINE SOLUTION BAG. ALARM "OCCLUSION UPSTREAM" WAS IN THE IVENIX LVP DISPLAY. IT WAS NOT POSSIBLE TO COMPLETE THE PRIMING PROCESS; IT DID NOT PASS SUCCESSFULLY. BACK PRIME WAS TESTED ON THE IVENIX INFUSION SYSTEM MACHINE. IT WAS POSSIBLE TO COMPLETE THE PROCESS; IT DID PASS SUCCESSFULLY. UNDER MICROSCOPE EXCESS OF GLUE WAS OBSERVED AROUND THE SECONDARY PORT. THE K-ZERO WAS REMOVED FROM THE SECONDARY PORT, AND NO INTERNAL OBSTRUCTION WAS FOUND. THE CUSTOMER COMPLAINT IS CONFIRMED. NO CONCLUSIVE ROOT CAUSE COULD BE DETERMINED DURING SAMPLE AUTOPSY. INSTEAD OF THE REPORTED "DOWNSTREAM OCCLUSION", "UPSTREAM OCCLUSION" ALARM WAS REPLICATED, ALL PROBABLE ROOT CAUSES WILL BE PRESENTED FOR BOTH ALARMS. PROBABLE ROOT CAUSES TO UPSTREAM OCCLUSION ALARM ARE THE FOLLOWING: AN UPSTREAM OCCLUSION ALARM IS TRIGGERED WHEN THE LVP CANNOT FILL THE IPC (PUMPING CHAMBER) OF THE ADMINISTRATION SET DUE TO THE INLET TUBING OF THE SET BEING KINKED OR THE SLIDE CLAMP BEING ACTUATED ON THE TUBING. SMALL SYRINGES CAN SOMETIMES CAUSE THIS TO TRIGGER WHEN INFUSING FROM THE SECONDARY ACCESS PORT (THROUGH THE SECONDARY LAV). THE SPIKE WAS NOT INSERTED CORRECTLY INTO THE SOLUTION BAG. PROBABLE ROOT CAUSES TO DOWNSTREAM OCCLUSION ALARM ARE THE FOLLOWING: 1) A DOWNSTREAM OCCLUSION ALARM OCCURS WHEN THE DISTAL LINE (TUBING EXITING THE CASSETTE) BUILDS UP PRESSURE DUE TO KINKS OR OCCLUSIONS UNTIL THE PRESSURE MATCHES THE SETTING AND THE ALARM IS TRIGGERED. 2) THE PUMP MEASURES THE PRESSURE WHEN THE DSPS (DOWNSTREAM PRESSURE SENSOR) ON THE DEVICE INTERACTS WITH THE DIAPHRAGM ON THE ADMINISTRATION SET. AS THE SET PRESSURIZES, THE DIAPHRAGM PUSHES ON THE SENSOR. WHEN THE THRESHOLD IS REACHED, THE PUMP TRIGGERS THE DOWNSTREAM OCCLUSION ALARM. THE CURRENT PROCESS CONTROLS DETECTION INCLUDE 1) 100% LEAK AND OCCLUSION TEST IS PERFORMED THROUGH THE LEAK AND OCCLUSION TEST MACHINE IN ORDER TO CAPTURE UNITS WITH ANY BLOCKAGE OR LEAK FAILURE MODE, 2) QUALITY SAMPLING FOR FINAL PHYSICAL TESTING, FOR PERFORMING A FLOW AND UNDERWATER LEAK TESTS, 3) 100% VISUAL INSPECTION RELATED TO KINKS DURING THE MANUFACTURING PROCESS AND FINAL PHYSICAL INSPECTIONS. THE BATCH RECORD FA25B17167 WAS REVIEWED. NO EXCEPTIONS WERE GENERATED THAT COULD CLASSIFY AS A POSSIBLE ROOT CAUSE OF THIS DEFECT. THE FINISHED GOOD LOT HAS PASSED ALL SAMPLING ACCEPTANCE CRITERIA FOR ALL TESTS PERFORMED INCLUDING IN-PROCESS TESTING AND PRODUCT TESTING. REPORTING AS A CONSERVATIVE MEASURE FOR THE INABILITY TO PRIME DURING EVALUATION. NO ADVERSE EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2365544 IVENIX, INC. LVP PRIMARY ADMINISTRATION SET, DUAL-INLET, LOW-SORBING, NEEDLE-FREE PORT, Y-SIT FPA FRESENIUS KABI USA, LLC SET-0013-1 FA25B17167 00811505030054

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown